NL
Ningxia LabsChem Co., Ltd.
CDMO · Shizuishan, China
Overview
Ningxia LabsChem (Chinese name 宁夏蓝博思化学技术有限公司, listed by FDA under both 'Ningxia Lanbosi Chemistry Technology' and 'Ningxia Labschem') was founded in March 2016 in the Pingluo pharmaceutical park, Shizuishan. It makes chemical APIs and intermediates and offers SPPS/LPPS peptide synthesis, purification and custom peptide API development and manufacturing. The FDA DMF list shows active Type II DMFs for semaglutide (Lanbosi name) and tirzepatide (Labschem name), plus orforglipron. Its site describes plants designed to FDA/EU/China GMP standards but cites no inspection.
Capabilities
- Semaglutide and tirzepatide API
- SPPS/LPPS peptide synthesis
- Peptide purification and analysis
- Custom peptide API development and manufacturing
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |